NCT05347082View on ClinicalTrials.gov

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 29, 2021

Primary Completion Date

December 29, 2021

Study Completion Date

February 20, 2022

Conditions
Postmenopausal OsteoporosisPostmenopauseHyperparathyroidism, SecondaryHypovitaminosis DHyperparathyroidism, Primary
Interventions
DRUG

Cholecalciferol

Tablets of 4000 IU

Trial Locations (1)

07300

Peri-postmenopause and bone metabolism clinic. Regional Hospital October 1st ISSSTE, Mexico City

All Listed Sponsors
collaborator

Universidad Nacional Autonoma de Mexico

OTHER

collaborator

National Polytechnic Institute, Mexico

OTHER

lead

Hospital Regional 1o de Octubre

OTHER